CA2905645C - Stable tigecycline composition - Google Patents

Stable tigecycline composition Download PDF

Info

Publication number
CA2905645C
CA2905645C CA2905645A CA2905645A CA2905645C CA 2905645 C CA2905645 C CA 2905645C CA 2905645 A CA2905645 A CA 2905645A CA 2905645 A CA2905645 A CA 2905645A CA 2905645 C CA2905645 C CA 2905645C
Authority
CA
Canada
Prior art keywords
tigecycline
solution
maltose
pharmaceutical composition
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CA2905645A
Other languages
English (en)
French (fr)
Other versions
CA2905645A1 (en
Inventor
Dhara PARIKH
Aditya Patel
Pallerla Bhaskar
Ashish Sehgal
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Intas Pharmaceuticals Ltd
Original Assignee
Intas Pharmaceuticals Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=54258937&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CA2905645(C) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Intas Pharmaceuticals Ltd filed Critical Intas Pharmaceuticals Ltd
Priority claimed from PCT/IN2014/000186 external-priority patent/WO2014167575A2/en
Publication of CA2905645A1 publication Critical patent/CA2905645A1/en
Application granted granted Critical
Publication of CA2905645C publication Critical patent/CA2905645C/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/65Tetracyclines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02Inorganic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/08Solutions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Inorganic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
CA2905645A 2013-03-26 2014-03-25 Stable tigecycline composition Active CA2905645C (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IN1127MU2013 IN2013MU01127A (https=) 2013-03-26 2013-03-26
IN1127/MUM/2013 2013-03-26
PCT/IN2014/000186 WO2014167575A2 (en) 2013-03-26 2014-03-25 Stable tigecycline composition

Publications (2)

Publication Number Publication Date
CA2905645A1 CA2905645A1 (en) 2014-10-16
CA2905645C true CA2905645C (en) 2021-02-16

Family

ID=54258937

Family Applications (1)

Application Number Title Priority Date Filing Date
CA2905645A Active CA2905645C (en) 2013-03-26 2014-03-25 Stable tigecycline composition

Country Status (9)

Country Link
US (1) US9511145B2 (https=)
EP (1) EP2978426B1 (https=)
CA (1) CA2905645C (https=)
ES (1) ES2766832T3 (https=)
HU (1) HUE047307T2 (https=)
IN (1) IN2013MU01127A (https=)
PL (1) PL2978426T3 (https=)
PT (1) PT2978426T (https=)
SI (1) SI2978426T1 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2021063468A1 (en) * 2019-10-02 2021-04-08 Anfarm Hellas S.A. Stable parenteral pharmaceutical composition containing tigecycline and process for the preparation thereof

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4870059A (en) * 1985-11-27 1989-09-26 Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo Dehydration of hydrous matter with anhydrous maltose
DE68908175T2 (de) 1988-05-27 1994-03-03 Centocor Inc Gefriergetrocknete formulierung für antikörperprodukte.
USRE40183E1 (en) 1991-10-04 2008-03-25 Wyeth Holdings Corporation 7-Substituted-9-substituted amino-6-demethyl-6-deoxytetracyclines
DE19936281C2 (de) 1999-08-02 2002-04-04 Bayer Ag Verfahren zur Gefriertrocknung
CN1568999A (zh) 2003-07-14 2005-01-26 南宁枫叶药业有限公司 稳定的医药用河豚毒素冷冻干燥制剂
KR20130122988A (ko) 2005-03-14 2013-11-11 와이어쓰 엘엘씨 티게사이클린 조성물 및 이의 제조방법
PE20070072A1 (es) 2005-06-16 2007-02-25 Wyeth Corp Proceso de manufactura para tigeciclina como polvo reconstituible
US9107929B2 (en) 2008-05-01 2015-08-18 Ranbaxy Laboratories Limited Stable parenteral formulations of tigecycline
US20100035845A1 (en) 2008-08-06 2010-02-11 Wyeth Tigecycline formulations
US20100197650A1 (en) 2008-08-28 2010-08-05 Forest Laboratories Holdings Ltd. Compositions and methods of treatment comprising ceftaroline
KR101799304B1 (ko) * 2010-05-12 2017-11-20 렘펙스 파머수티클스 인코퍼레이티드 테트라사이클린 조성물

Also Published As

Publication number Publication date
US20160058865A1 (en) 2016-03-03
SI2978426T1 (sl) 2020-03-31
PL2978426T3 (pl) 2020-05-18
IN2013MU01127A (https=) 2015-05-01
CA2905645A1 (en) 2014-10-16
US9511145B2 (en) 2016-12-06
EP2978426A2 (en) 2016-02-03
EP2978426A4 (en) 2016-11-30
HUE047307T2 (hu) 2020-04-28
PT2978426T (pt) 2020-02-14
EP2978426B1 (en) 2019-11-13
ES2766832T3 (es) 2020-06-15

Similar Documents

Publication Publication Date Title
KR101354093B1 (ko) 티게사이클린 조성물 및 이의 제조방법
AU2016250816B2 (en) Cationic steroidal antimicrobial salts
DK2568987T3 (en) Tetracycline COMPOSITIONS
CA2985740A1 (en) Cationic steroidal antimicrobial compounds and methods of manufacturing such compounds
EP3528786B1 (en) Liquid formulations of daptomycin
CA2905645C (en) Stable tigecycline composition
US20170196899A1 (en) Stable pharmaceutical compositions
KR20110111494A (ko) 티게사이클린의 단리방법
EA036750B1 (ru) Лиофилизированная парентеральная композиция тигециклина и способ ее приготовления
WO2014167575A2 (en) Stable tigecycline composition
EP3003273A1 (en) A method for stabilizing tigecycline
US20140323443A1 (en) Tigecycline formulations
WO2014032956A1 (en) Tigecycline formulations
CN104107170A (zh) 一种替加环素组合物
WO2021063468A1 (en) Stable parenteral pharmaceutical composition containing tigecycline and process for the preparation thereof
HK1171948A (en) Tigecycline compositions and methods of preparation

Legal Events

Date Code Title Description
EEER Examination request

Effective date: 20190103

MPN Maintenance fee for patent paid

Free format text: FEE DESCRIPTION TEXT: MF (PATENT, 11TH ANNIV.) - STANDARD

Year of fee payment: 11

U00 Fee paid

Free format text: ST27 STATUS EVENT CODE: A-4-4-U10-U00-U101 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE REQUEST RECEIVED

Effective date: 20241107

U11 Full renewal or maintenance fee paid

Free format text: ST27 STATUS EVENT CODE: A-4-4-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT DETERMINED COMPLIANT

Effective date: 20241121

Free format text: ST27 STATUS EVENT CODE: A-4-4-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT PAID IN FULL

Effective date: 20241121

MPN Maintenance fee for patent paid

Free format text: FEE DESCRIPTION TEXT: MF (PATENT, 12TH ANNIV.) - STANDARD

Year of fee payment: 12

U00 Fee paid

Free format text: ST27 STATUS EVENT CODE: A-4-4-U10-U00-U101 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE REQUEST RECEIVED

Effective date: 20260304

U11 Full renewal or maintenance fee paid

Free format text: ST27 STATUS EVENT CODE: A-4-4-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT PAID IN FULL

Effective date: 20260304